BPC-157 may also be appropriate for selected patients with gut irritation, inflammatory gut symptoms, gastritis-type symptoms, reflux-type irritation, or medication-related GI irritation when it is part of a broader gut-health plan
Research Use Limitation BPC-157 is NOT approved by FDA or EMA for human use
BPC-157 is not FDA-approved for therapeutic use and should be considered investigational
Laboratory research suggests potential effects including: stimulation of angiogenesis (formation of new blood vessels) improved collagen organization accelerated tendon and ligament healing anti-inflammatory effects Animal studies have demonstrated promising results in muscle, tendon, ligament, and bone injury models
Adding TB-500, KPV, or other peptides increases compounding costs and protocol complexity